Adenopect, created in 1966 (Germany), from 1125 sister brands and 17477 competing brands. Adenopect is a brand of Pfizer Inc, listed on the stock exchange of New York. Adenopect belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Pfizer Inc
(Adenopect)
over 5 years*
USD 18.24